FOXO Signaling Pathways as Therapeutic Targets in Cancer
暂无分享,去创建一个
Haitao Wang | Mohd Farhan | Jiangping Xu | U. Gaur | Wenhua Zheng | P. Little | Mohd Farhan | Haitao Wang | Jiang-Ping Xu | Wenhua Zheng | Peter J. Little | Uma Gaur | Jiangping Xu
[2] Fengxia Yan,et al. Amiodarone-Induced Retinal Neuronal Cell Apoptosis Attenuated by IGF-1 via Counter Regulation of the PI3k/Akt/FoxO3a Pathway , 2016, Molecular Neurobiology.
[3] Fengxia Yan,et al. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] M. Buchfelder,et al. Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency , 2016, Oncoscience.
[5] Wenhua Zheng,et al. Evaluation of the potential synergism of imatinib‐related poly kinase inhibitors using growth factor stimulated proteoglycan synthesis as a model response , 2016, The Journal of pharmacy and pharmacology.
[6] Limei Qin,et al. miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1 , 2016, Tumor Biology.
[7] M. Kamal,et al. Telomeric Repeat Containing RNA (TERRA): Aging and Cancer. , 2015, CNS & neurological disorders drug targets.
[8] N. Wheate,et al. The state-of-play and future of platinum drugs. , 2015, Endocrine-related cancer.
[9] P. Urbánek,et al. Redox regulation of FoxO transcription factors , 2015, Redox biology.
[10] MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1 , 2015, Molecular and Cellular Biochemistry.
[11] MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1 , 2014, BMC Cancer.
[12] S. S. Yadav,et al. Down Regulation of FOXO1 Promotes Cell Proliferation in Cervical Cancer , 2014, Journal of Cancer.
[13] D. Graves,et al. FOXO Transcription Factors: Their Clinical Significance and Regulation , 2014, BioMed research international.
[14] David A. Frank,et al. Targeting transcription factors: promising new strategies for cancer therapy , 2013, Current opinion in oncology.
[15] S. Andò,et al. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness , 2013, Cell cycle.
[16] Sang-Mo Kwon,et al. Angiogenesis and Its Therapeutic Opportunities , 2013, Mediators of inflammation.
[17] J. Cheng,et al. IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function , 2013, PloS one.
[18] Rikang Wang,et al. The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells , 2013, Psychopharmacology.
[19] R. Young,et al. Transcriptional Regulation and Its Misregulation in Disease , 2013, Cell.
[20] X. Mao,et al. Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1 , 2012, PloS one.
[21] Hui Zhang,et al. miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer. , 2012, Oncology letters.
[22] Harald J. Maier,et al. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma. , 2012, Blood.
[23] D. Xing,et al. A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation , 2012, Journal of cellular physiology.
[24] G. Poli,et al. Tumor suppressor genes and ROS: complex networks of interactions. , 2012, Free radical biology & medicine.
[25] K. Tachibana,et al. FoxO3a Functions as a Key Integrator of Cellular Signals That Control Glioblastoma Stem‐like Cell Differentiation and Tumorigenicity , 2011, Stem cells.
[26] A. Klagge,et al. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide. , 2011, The Journal of clinical endocrinology and metabolism.
[27] Ophelia S. Venturelli,et al. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor , 2011, Oncogene.
[28] W. Kim,et al. Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules , 2011, BMC Cancer.
[29] Libing Song,et al. Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.
[30] F. Agou,et al. IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. , 2010, Blood.
[31] Lara J. Monteiro,et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. , 2009, Cancer research.
[32] F. Barr,et al. Tumorigenesis and Neoplastic Progression High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human Myoblasts , 2022 .
[33] C. Kemp,et al. Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer , 2009, Oncogene.
[34] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[35] B. White,et al. Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.
[36] A. Toker,et al. FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases , 2009, Molecular and Cellular Biology.
[37] K. Maiese,et al. A “FOXO” in sight: Targeting Foxo proteins from conception to cancer , 2009, Medicinal research reviews.
[38] D. Polsky,et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.
[39] Yong Zhao,et al. New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder. , 2009, Advances in experimental medicine and biology.
[40] Kenneth Maiese,et al. Forkhead transcription factors. , 2010 .
[41] T. Mak,et al. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. , 2008, Journal of molecular biology.
[42] S. Cook,et al. Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM , 2008, Oncogene.
[43] E. Lam,et al. Resist or die: FOXO transcription factors determine the cellular response to chemotherapy , 2008, Cell cycle.
[44] K. Maiese,et al. Rogue proliferation versus restorative protection: Where do we draw the line for Wnt and Forkhead signaling? , 2008, Expert opinion on therapeutic targets.
[45] K. Maiese,et al. Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies , 2008, Progress in Neurobiology.
[46] M. Ladanyi,et al. Identification of PAX3‐FKHR‐regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus on MYCN as a biologically relevant target , 2008, Genes, chromosomes & cancer.
[47] K. Maiese,et al. Erythropoietin and oxidative stress. , 2008, Current neurovascular research.
[48] D. Tindall,et al. FOXOs, cancer and regulation of apoptosis , 2008, Oncogene.
[49] E. Lam,et al. Many forks in the path: cycling with FoxO , 2008, Oncogene.
[50] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[51] M. Essers,et al. Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity* , 2008, Journal of Biological Chemistry.
[52] K. Maiese. Diabetic stress: new triumphs and challenges to maintain vascular longevity , 2008, Expert review of cardiovascular therapy.
[53] C. Emanueli,et al. Identification of the prosurvival activity of nerve growth factor on cardiac myocytes , 2008, Cell Death and Differentiation.
[54] G. Mills,et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation , 2008, Nature Cell Biology.
[55] K. Sakamoto,et al. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis , 2008, Molecular and Cellular Endocrinology.
[56] K. Walsh,et al. Forkhead Transcription Factors and Cardiovascular Biology , 2007 .
[57] J. Lazarewicz,et al. Nicotinamide and 1-methylnicotinamide reduce homocysteine neurotoxicity in primary cultures of rat cerebellar granule cells. , 2008, Acta neurobiologiae experimentalis.
[58] K. Ozawa,et al. Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia‐derived cell lines via the production of tumor necrosis factor‐related apoptosis‐inducing ligand , 2007, Cancer science.
[59] K. Maiese,et al. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. , 2007, Histology and histopathology.
[60] Soyoung Lee,et al. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf. , 2007, Genes & development.
[61] E. Lam,et al. The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.
[62] M. Essafi,et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a , 2007, Oncogene.
[63] S. Kane,et al. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. , 2007, Cancer research.
[64] G. Tuteja,et al. SnapShot:Forkhead Transcription Factors I , 2007, Cell.
[65] Zhiwei Wang,et al. Regulation of FOXO3a/β-Catenin/GSK-3β Signaling by 3,3′-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer Cells* , 2007, Journal of Biological Chemistry.
[66] K. Maiese,et al. Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signaling pathways. , 2007, Cellular signalling.
[67] K. Nowak,et al. E2F-1 regulates expression of FOXO1 and FOXO3a. , 2007, Biochimica et Biophysica Acta.
[68] K. Maiese,et al. Erythropoietin involves the phosphatidylinositol 3‐kinase pathway, 14‐3‐3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity , 2007, British journal of pharmacology.
[69] S. Armstrong,et al. FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.
[70] Yonghong Xiao,et al. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.
[71] R. Mägi,et al. Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age , 2007, European Journal of Human Genetics.
[72] Zhiwei Wang,et al. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. , 2007, The Journal of biological chemistry.
[73] M. Hu,et al. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[74] H. Otu,et al. A Novel Class of Vascular Endothelial Growth Factor-responsive Genes That Require Forkhead Activity for Expression* , 2006, Journal of Biological Chemistry.
[75] E. Lam,et al. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. , 2006, Molecular endocrinology.
[76] K. Maiese,et al. Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of Glycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB , 2006 .
[77] T. Mak,et al. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[78] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[79] Keshav K. Singh. Mitochondria Damage Checkpoint, Aging, and Cancer , 2006, Annals of the New York Academy of Sciences.
[80] K. Maiese,et al. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress. , 2006, Current neurovascular research.
[81] Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation , 2006, Neuroscience Letters.
[82] H. Shin,et al. Polymorphisms in FOXO Gene Family and Association Analysis with BMI , 2006, Obesity.
[83] N. Ahmad,et al. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells. , 2006, Cancer research.
[84] K. Maiese,et al. Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB. , 2006, Current neurovascular research.
[85] R. Coombes,et al. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. , 2006, Cancer research.
[86] E. Greer,et al. FOXO transcription factors at the interface between longevity and tumor suppression , 2005, Oncogene.
[87] R. DePinho,et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. , 2005, The Journal of clinical investigation.
[88] K. Maiese,et al. mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways. , 2005, Current neurovascular research.
[89] Hendrik C Korswagen,et al. Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.
[90] M. Gorospe,et al. Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity , 2005, The Journal of cell biology.
[91] J. Graff,et al. The Progression of LNCaP Human Prostate Cancer Cells to Androgen Independence Involves Decreased FOXO3a Expression and Reduced p27KIP1 Promoter Transactivation , 2005, Molecular Cancer Research.
[92] K. Maiese,et al. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease , 2005, Progress in Neurobiology.
[93] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[94] J. Bos,et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK , 2004, The EMBO journal.
[95] B. Pettmann,et al. Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK , 2004, BMC Neuroscience.
[96] Benjamin R. Arenkiel,et al. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. , 2004, Genes & development.
[97] K. Maiese,et al. The NAD+ Precursor Nicotinamide Governs Neuronal Survival During Oxidative Stress Through Protein Kinase B Coupled to FOXO3a and Mitochondrial Membrane Potential , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[98] Michael G. Kharas,et al. Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells. , 2004, Blood.
[99] Marten P Smidt,et al. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. , 2004, The Biochemical journal.
[100] J. Griffin,et al. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins , 2004, Oncogene.
[101] Ryuji Kobayashi,et al. IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.
[102] K. Maiese,et al. The Tyrosine Phosphatase SHP2 Modulates MAP Kinase p38 and Caspase 1 and 3 to Foster Neuronal Survival , 2003, Cellular and Molecular Neurobiology.
[103] Ryuji Kobayashi,et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. , 2004, Cell.
[104] C. Sugimoto,et al. PI3K/Akt and apoptosis: size matters , 2003, Oncogene.
[105] K. Maiese,et al. Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity , 2003, Journal of neuroscience research.
[106] P. Wijchers,et al. FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics* , 2003, Journal of Biological Chemistry.
[107] Hitomi Matsuzaki,et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[108] K. Maiese,et al. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. , 2003, Molecular pharmacology.
[109] K. Maiese,et al. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. , 2003, Trends in pharmacological sciences.
[110] A. Cuadrado,et al. Nerve Growth Factor Protects against 6-Hydroxydopamine-induced Oxidative Stress by Increasing Expression of Heme Oxygenase-1 in a Phosphatidylinositol 3-Kinase-dependent Manner* , 2003, The Journal of Biological Chemistry.
[111] K. Maiese,et al. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase‐mediated pathways , 2003, British journal of pharmacology.
[112] G. Grosveld,et al. Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors , 2002, Molecular and Cellular Biology.
[113] Geert J. P. L. Kops,et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress , 2002, Nature.
[114] S. Catarzi,et al. The role of H2O2 in the platelet-derived growth factor-induced transcription of the γ-glutamylcysteine synthetase heavy subunit , 2002, Cellular and Molecular Life Sciences CMLS.
[115] N. Motoyama,et al. FOXO Forkhead Transcription Factors Induce G2-M Checkpoint in Response to Oxidative Stress* , 2002, The Journal of Biological Chemistry.
[116] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[117] P. Cohen,et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion , 2002, The EMBO journal.
[118] Wenhua Zheng,et al. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling , 2002, Journal of neurochemistry.
[119] P. Cohen,et al. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. , 2001, The Biochemical journal.
[120] K. Maiese,et al. The Metabotropic Glutamate Receptor System Protects against Ischemic Free Radical Programed Cell Death in Rat Brain Endothelial Cells , 2001 .
[121] Brian A. Hemmings,et al. Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a) , 2001, Molecular and Cellular Biology.
[122] K. Maiese,et al. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[123] R. Quirion,et al. Insulin-like Growth Factor-1-induced Phosphorylation of the Forkhead Family Transcription Factor FKHRL1 Is Mediated by Akt Kinase in PC12 Cells* , 2000, The Journal of Biological Chemistry.
[124] J. Lammers,et al. Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1 , 2000, Molecular and Cellular Biology.
[125] D. Yee,et al. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells , 2000, Oncogene.
[126] K. Ozawa,et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. , 2000, Blood.
[127] D. Accili,et al. Differential regulation of gene expression by insulin and IGF‐1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR , 2000, The EMBO journal.
[128] T. Rabbitts,et al. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene , 2000, The EMBO journal.
[129] Y. Suh,et al. Cell transformation by the superoxide-generating oxidase Mox1 , 1999, Nature.
[130] P. Cohen,et al. Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B* , 1999, The Journal of Biological Chemistry.
[131] D. Accili,et al. Insulin Stimulates Phosphorylation of the Forkhead Transcription Factor FKHR on Serine 253 through a Wortmannin-sensitive Pathway* , 1999, The Journal of Biological Chemistry.
[132] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[133] C. Kenyon,et al. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. , 1997, Science.
[134] R. Berger,et al. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. , 1997, Blood.
[135] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[136] J. Zweier,et al. Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.
[137] Arndt Borkhardt,et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) , 1997, Oncogene.
[138] F. Barr,et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 , 1995, Molecular and cellular biology.
[139] Yalin H. Wei,et al. Cloning and characterization of the t(X;II) breakpoint from a leukemic cell line identify a new member of the forkhead gene family , 1994, Genes, chromosomes & cancer.
[140] J. Biegel,et al. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.
[141] B. Emanuel,et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.
[142] C. Nathan,et al. Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.
[143] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.